Luminex develops, manufactures and sells biological testing technologies and products with applications in the life sciences industries, including diagnostics, pharmaceutical and research. Co. delivers its products to various market segments, including multiplexing, reduction of labor and ability to test for proteins and nucleic acids. Co.'s products include: instruments, which include Luminex® 100/200™, FLEXMAP® 3D, MAGPIX®, ARIES®, and ARIES® M1; consumables, which include MicroPlex® Microspheres, MagPlex® Microspheres, and xTAG® Microspheres; software, which includes xPONENT®, TDAS®, SYNCT™, and IDEAS®; and clinical diagnostic assay product families, which include ARIES® Cassettes. We show 46 historical shares outstanding datapoints in our LMNX shares outstanding history coverage, used to compute LMNX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LMNX market cap history over the course of time is important for investors
interested in comparing LMNX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LMNX versus a peer is one thing; comparing
LMNX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LMNX can fluctuate over the course of history.
With this page we aim to empower investors researching LMNX by allowing them to research the LMNX market cap history. |
Free LMNX Email Alerts:
Video: The Importance of Market Cap
